![Integra Lifesciences Holdings 주식 Integra Lifesciences Holdings 주식](https://logo.eulerpool.com/p/US4579852082.png)
Integra Lifesciences Holdings AAQS 2024
Integra Lifesciences Holdings AAQS
5
티커
IART
ISIN
US4579852082
WKN
897013
Integra Lifesciences Holdings의 현재 AAQS는 5입니다.
높은 AAQS는 회사가 성공적으로 발전하고 있다는 긍정적인 지표로 여겨질 수 있습니다.
투자자들은 이 회사가 수익을 창출하는데 좋은 길 위에 있다고 생각할 수 있습니다.
다른 한편으로, Integra Lifesciences Holdings 주식의 AAQS를 달성한 이익과 같은 업계의 다른 회사들과 비교하는 것이 중요합니다. 높은 AAQS는 반드시 긍정적인 미래를 보장하는 것은 아닙니다. 이를 통해서만 회사의 성과에 대한 전체적인 그림을 얻을 수 있습니다.
회사의 발전을 더 잘 파악하기 위해, 동일 업계의 다른 회사들과 비교하여 AAQS를 조사하는 것이 중요합니다. 일반적으로 투자자들은 이익, EBIT, 현금 흐름 등 다른 지표들과 함께 회사의 AAQS를 항상 고려하여 투자 결정을 내려야 합니다.
Integra Lifesciences Holdings Aktienanalyse
Integra Lifesciences Holdings는 무엇을 하나요?
Integra Lifesciences Holdings Corp is a multinational manufacturer and provider of medical devices, implants, and instruments. The company is headquartered in Plainsboro, New Jersey and was founded in 1989. Integra Lifesciences specializes in the development and marketing of products for orthopedic surgery, neurosurgery, and plastic and reconstructive surgery. The company has a wide range of products that have been constantly improved and expanded over the years. The history of Integra Lifesciences is characterized by continuous expansion through the acquisition of other companies. In 1996, the company acquired Confluent Surgical, which allowed them to enter the tissue adhesive sector. In the following years, several companies were acquired, including Depuy Orthopaedics, Kaye Surgical, and SeaSpine Holdings. Each acquisition has contributed to Integra Lifesciences being able to offer its customers an extensive product portfolio that meets all requirements. Integra Lifesciences has a diversified business model that focuses on four different divisions: anesthesia, neurosurgery, plastic and reconstructive surgery, and orthopedic surgery. Each division has its own range of products that are tailored to the specific requirements of its customers. Integra Lifesciences supplies high-quality medical instruments that are valued by surgeons around the world. These include products such as bone cement, implants, skull plates, bone screws, tissue adhesives, and spinal fusion devices. All products from Integra Lifesciences aim to improve patient care and enhance patients' quality of life. The anesthesia division offers a wide range of products and technologies that improve the administration of anesthesia and enable optimal patient care. In addition to traditional products such as anesthesia masks and tubes, Integra Lifesciences also develops innovative products such as disposable ventilation systems that can increase safety and efficiency. The neurosurgery division offers a wide range of devices and implants for the treatment of brain and spinal cord conditions. The product range includes skull plates, bone connectors, and devices for performing brain surgeries. In the plastic and reconstructive surgery division, Integra Lifesciences offers products for the treatment of burns and the reconstruction of bones and soft tissues. The company has a wide range of products, including skin grafts, scar treatment, and liposuction. Orthopedic surgery is one of the established divisions at Integra Lifesciences, offering a wide range of products for the treatment of bone and joint problems. The company provides implants and instruments for all types of orthopedic procedures, including hip and knee replacements, spinal fusion, and limb reconstruction. Overall, Integra Lifesciences Holdings Corp is a leading manufacturer of medical devices, implants, and instruments specializing in the fields of orthopedics, neurosurgery, and plastic and reconstructive surgery. With its comprehensive product range and innovative technologies, Integra Lifesciences has gained a leading position in the industry, providing its customers worldwide with the highest quality and safety. Integra Lifesciences Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.Integra Lifesciences Holdings 주식에 대한 자주 묻는 질문
주식 저축계획은 투자자가 장기적으로 자산을 쌓아가는 매력적인 방법을 제공합니다. 주요 장점 중 하나는 이른바 '비용 평균 효과'인데, 이는 정기적으로 일정 금액을 주식이나 주식 펀드에 투자함으로써 가격이 낮을 때 자동으로 더 많은 비율을, 가격이 높을 때는 적은 비율을 구매하게 되므로 시간이 지남에 따라 주식 당 평균 매입 가격을 낮출 수 있습니다. 또한 주식 저축계획은 소규모 투자자도 소액으로 비싼 주식에 접근할 수 있도록 해주며, 규칙적인 투자는 규율 있는 투자 전략을 촉진하고 충동적인 매수나 매도와 같은 감정적인 결정을 피하는 데 도움이 됩니다. 게다가 투자자는 주식의 잠재적인 가치 상승뿐만 아니라 배당금 분배로부터도 이익을 얻을 수 있으며, 이를 재투자함으로써 복리 효과를 증대시켜 투자 자본의 성장을 강화할 수 있습니다.
Andere Kennzahlen von Integra Lifesciences Holdings
Integra Lifesciences Holdings 매출 주식에 대한 우리의 주식 분석은 매출, 이익, P/E 비율, P/S 비율, EBIT, 배당금에 대한 정보를 포함하며, 또한 주식, 시가 총액, 부채, 자기자본 및 Integra Lifesciences Holdings 매출의 채무와 같은 측면을 고려합니다. 이러한 주제에 대한 더 자세한 정보를 찾으시는 경우, 우리의 하위 페이지에서 자세한 분석을 제공합니다:
- Integra Lifesciences Holdings 매출
- Integra Lifesciences Holdings 이익
- Integra Lifesciences Holdings PER
- Integra Lifesciences Holdings KUV
- Integra Lifesciences Holdings EBIT
- Integra Lifesciences Holdings 배당금
- Integra Lifesciences Holdings 주식
- Integra Lifesciences Holdings 시가 총액
- Integra Lifesciences Holdings 부채
- Integra Lifesciences Holdings 부채
- Integra Lifesciences Holdings 자기자본
- Integra Lifesciences Holdings AAQS
- Integra Lifesciences Holdings 직원
- Integra Lifesciences Holdings ROE
- Integra Lifesciences Holdings ROA
- Integra Lifesciences Holdings ROCE